Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MICHAEL J LABANCE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1205368800
CMS profile
1287863
Location
PINELLAS PARK, FL

General Payments · PY2019–2022

$65,931.96

  • Reported across 50 records
  • CMS publication 2026-06-30

Latest program year · PY2022

$14,000.00

10 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $14,000.00 10

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $14,000.00 10

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,056.96 13
PY2020 $19,275.00 15
PY2021 $16,600.00 12
PY2022 $14,000.00 10

Payment records · PY2022 (10)

Sorted by paying entity, then date · as published by CMS

Program year 2022 201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 01/11/2022 Consulting Fee Undisputed 06/30/2026 955693685 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 02/07/2022 Consulting Fee Undisputed 06/30/2026 955693689 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 03/08/2022 Consulting Fee Undisputed 06/30/2026 955693693 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 04/09/2022 Consulting Fee Undisputed 06/30/2026 955693695 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 05/09/2022 Consulting Fee Undisputed 06/30/2026 955693699 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 06/06/2022 Consulting Fee Undisputed 06/30/2026 955693703 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 07/13/2022 Consulting Fee Undisputed 06/30/2026 955693705 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 08/17/2022 Consulting Fee Undisputed 06/30/2026 955693709 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 09/09/2022 Consulting Fee Undisputed 06/30/2026 955693713 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,400.00 10/05/2022 Consulting Fee Undisputed 06/30/2026 955693717 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.